Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01305291 · ClinicalTrials.gov registry record · NA
Fibersol-2 Clinical Trials Related to Appetite
A NA study, sponsored by Iowa State University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01305291: Completed NA study, sponsored by Iowa State University.
NCT01305291 is a NA study that has completed, run by Iowa State University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01305291, a NA study, has completed, sponsored by Iowa State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Emerging research suggests fiber, particularly digestion-resistant maltodextrins such as Fibersol-2, may impact satiety, by decreasing hunger, prolonging satiation, and/or increasing satiety signals from the gut. This research aims to determine whether or not Fibersol-2 may impact satiety, by decreasing hunger, prolonging satiation, and/or increasing satiety signals from the gut.
Primary Outcome
Hunger survey (30 minutes before meal and every half hour for 4 hours postprandial) (analogue scores)
Interventions
- OTHER placebo
- DIETARY_SUPPLEMENT digestion-resistant maltodextrin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-11 |
| Phase | NA |
What the finished NCT01305291 record still lists
NCT01305291 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01305291 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01305291 about?
NCT01305291 is a clinical study titled "Fibersol-2 Clinical Trials Related to Appetite". Emerging research suggests fiber, particularly digestion-resistant maltodextrins such as Fibersol-2, may impact satiety, by decreasing hunger, prolonging satiation, and/or increasing satiety signals from the gut. This research aims to determine whether or not Fibersol-2 may impact satiety, by decrea...
What is the current status of trial NCT01305291?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2008-11. Estimated completion is 2009-11.
What interventions are being tested in trial NCT01305291?
The interventions under investigation include: placebo (OTHER), digestion-resistant maltodextrin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01305291?
This trial is sponsored by Iowa State University, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01305291's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia